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Abstract The quadruple mutation of the whole basic cluster, 
K74KKK 77 conserved in the catalytic subunits of protein kinase 
CK2 and implicated in substrate recognition, not only abolishes 
inhibition by heparin but even induces with some peptide sub- 
strates an up to 5-fold stimulation by heparin in the 0.5-5/tg/ml 
concentration range. Two other mutants defective in substrate 
recognition, R191,195K198A and K79R80K83A, display either 
a 100-fold reduction or no alteration at all in heparin inhibition, 
respectively. In contrast sensitivity to heparin inhibition is in- 
creased 30-fold by a single mutation affecting Arg-228 while it 
is not altered by a triple mutation in the small insert of subdomain 
XI (mutant R278K279R280A). The effect of the same mutations 
on inhibition by pseudosubstrate EEEEEYEEEEEEE is differ- 
ent, the mutant displaying the most reduced sensitivity being 
R191,195K198A, followed by K74-77A and K79R80K83A; the 
other mutants are almost indistinguishable from CK2 wild type. 
Substantial reduction of inhibition by poly(Glu,Tyr)4:l is only 
observable with mutant R191,195K198A, whereas R228A is sig- 
nificantly more sensitive to inhibition. These data show that the 
mode of inhibition of CK2 by polyanionic compounds occurs 
through substantially different mechanisms involving residues 
that are variably concerned with substrate recognition. 
Key words: Protein kinase CK2; Mutants of CK2; Heparin; 
Poly(Glu,Tyr)4:l; CK2 pseudosubstrate; Inhibitors of CK2 
1. Introduction 
Protein kinase CK2 (formerly termed casein kinase-2 or -II) 
is a ubiquitous, Ser/Thr specific protein kinase responsible for 
the phosphorylation f a myriad of protein substrates and sup- 
posed to play a central albeit still enigmatic role in cell regula- 
tion (reviewed in [14]). Its activity is invariably elevated in 
proliferating and transformed tissues [3] and recent experi- 
ments with transgenic mice showed that CK2 catalytic subunit 
may act like an oncogene [5]. CK2 is normally composed of two 
catalytic (a and/or  a') and two non catalytic fl-subunits tightly 
associated to give a fully active stable heterotetrameric holoen- 
zyme. Although CK2 is spontaneously active toward most of 
its substrates and it is not subjected to any strict control medi- 
ated by either known second messengers or phosphorylation, 
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it is generally accepted that its activity can be subtly modulated 
by its non catalytic fl-subunit. Reconstitution experiments with 
mutants and synthetic fragments of the fl-subunit have dis- 
closed a dual function of this protein which on one side protects 
the catalytic subunits against denaturing agents and increases 
its basal activity [6], on the other side exhibits an intrinsic 
down-regulation, becoming especially evident if calmodulin is 
the substrate [7]. Down-regulation by the fl-subunit is mediated 
by acidic residues clustered in its N-terminal moiety whose 
mutation to alanines consequently gives rise to hyperactivating 
fl-subunits [8,9]. This would imply the presence of complemen- 
tary basic residues in the catalytic subunits. A crucial role of 
basic residues in CK2 is highlighted by other properties as well, 
notably its unusual site specificity, determined by rows of acidic 
residues mostly located own-stream from the target aminoacid 
[1] and its extreme sensitivity to polyanionic inhibitors, such as 
heparin [10] and the random polymers poly(Glu,Tyr)4:l [11]. 
In order to identify the structural elements responsible for these 
peculiar properties of CK2 we have started to mutate the con- 
served basic residues of human a-subunit hat are divergent 
from the homologous residues in the majority of Ser/Thr pro- 
tein kinases, which are basophilic instead of acidophilic like 
CK2. In a previous report we have analysed the catalytic activ- 
ity of six such mutants and found that three of them were 
defective in substrate recognition [12]. Here these mutants, pu- 
rified to near homogeneity, are exploited to localize the residues 
responsible for the binding of different classes of anionic inhib- 
itors. 
2. Materials and methods 
Expression of human CK2 a and fl subunits and of mutated CK2 
subunits, was performed as previously described [12-14]. Soluble ex- 
tracts of bacteria expressing CK2 a subunits, either wild type or mu- 
tants were combined with the extracts containing the fl subunit and the 
holoenzymes, resulting from equimolar combination of a and fl sub- 
units, were purified by phosphocellulose chromatography followed by 
Mono Q FPLC, by a procedure that will be detailed elsewhere. By such 
a procedure all five mutants were purified to near homogeneity as 
heterotetrameric enzymes as judged from both PAGE/SDS coomassie 
patterns showing two prominent bands of a and fl subunit in about he 
same ratio as CK2 wild type, and sucrose gradient ultracentrifugation, 
revealing peaks of activity with the same sedimentation coefficient as 
CK2 wild type. The specific activities were: CK2 wild type 300 U/mg, 
K74-77A 27 U/mg, K79R80K83A 93 U/mg, R 191,195K 198A 40 U/mg, 
R228A 450 U/rag, R278K279R280A 370 U/mg, one unit being equiva- 
lent to one nmol P incorporated into the peptide substrate, RRRAD- 
DSDDDDD, per min, under our experimental conditions. Synthetic 
peptides were prepared as described or referenced in [12]. The assay of 
CK2 activity was performed as in [15], by 10 min incubation at 37 ° C 
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in the presence of 100 ,uM peptide substrate (unless differently indi- 
cated). The inhibitory pseudosubstrate peptide EEEEEYEEEEEEE 
was prepared by Fmoc solid-phase chemistry using an automatic pep- 
tide synthesizer (Model 431-A Applied Biosystem). 
Heparin (average Mr=14,000) and the random polymer poly(Glu/ 
Tyr)4:l (average M,=49,100) were from Sigma. All the other chemicals 
were of the highest quality commercially available. 
3. Results and discussion 
Fig. 1 shows the effect of increasing concentrations of hepa- 
rin on the activity of CK2 wild type and five mutants in which 
basic residues have been variably replaced by alanines. All the 
assays were performed using the best known peptide substrate 
for CK2 [16] RRRADDSDDDDD, in which all the positions 
between -2 and +5, where acidic residues are known to act as 
positive determinants [1], are occupied by aspartic acid. While 
the inhibition of two mutants, K79R80K83A and 
R278K279R280A, is indistinguishable from that of CK2 wild 
type (ICs0 values around 0.1 ~g/ml) the other mutants display 
deeply altered heparin sensitivity. Mutant R228A is more read- 
ily inhibited than CK2 w.t.; in contrast mutant 
R191,195K198A is less susceptible and mutant K74-77A is 
totally refractory to inhibition. The behaviour of K74-77A is 
especially remarkable since it not only is insensitive to inhibi- 
tion (up to 120/zg/ml heparin) but even is significantly stimu- 
lated by heparin concentrations around 1/.tg/ml. 
The relevance of the substrate in determining such a para- 
doxical stimulation by heparin of CK2 mutant K74 77A is 
highlighted by the data of Fig. 2 showing that the extent of 
stimulation is enhanced to up to 5-fold if the optimal peptide 
substrate is replaced by its derivative in which a single aspartyl 
residue at position -2 (rather unimportant for substrate recog- 
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Fig. 1. Effect of increasing heparin concentration the catalytic activ- 
ities of wild type and variably mutated CK2. CK2 activity was assayed 
on the peptide substrate RRRADDSDDDDD [100 ,uM]. The same 
amount (0.1/tg) of either CK2 wild type (o) or mutants K74-77A (A), 
K79R80K83A (x) R191,195K198A (A) R228A (D) and 
R278K279R280A (m) was used in all experiments. 
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Fig. 2. Stimulation of the catalytic activity of CK2 mutant K74-77A 
by heparin is dependent on the structure of the peptide substrate. 
Experimental conditions are the same as in Fig. 1 except for the replace- 
ment of peptide RRRADDSDDDDD with RRRAADSDDDDD (O), 
RRRADDSDADDD (A), RRRADDSDDADD ([]) and RRKDLH- 
DDEEDEEMSTADGE (o). 
nition) is replaced by alanine. In contrast stimulation is nearly 
undetectable with other two peptide substrates. With one of 
these, RRKDLHDDEEDEEMSETADGE, lacking the crucial 
acidic determinant a position +3, but still having the one at 
position + 1, no stimulation occurs while a slight inhibition is 
observable reaching about 40% with 120 j~g/ml heparin. 
The notion that the 74-80 basic stretch unique to CK2 is 
implicated in heparin inhibition was already provided by dou- 
ble mutations of K74/K75 [16] and K75/K76 [17] giving rise to 
enzymes defective in this property. Interestingly however these 
mutations caused a 70- and 13-fold increase of ICs0 values, 
respectively, but they did not suppress heparin inhibition as it 
is observed with the quadruple mutated K74-77A mutant used 
here. This may suggest that all the four, 74, 75, 76, and 77 basic 
residues are implicated in heparin binding and the mutation of 
all of them is necessary to minimize heparin inhibition and to 
disclose the paradoxical stimulation by heparin, which is evi- 
dent with some peptide substrates ( ee Fig. 2). In striking con- 
trast the basic residues just down-stream from K77, namely 
K79, RS0 and R83, very important for substrate recognition 
[12] are not concerned at all with heparin inhibition, since their 
triple mutation does not alter the ICs0 value (see Table 1). 
It should be concluded therefore that the highly conserved 
74--80 basic stretch unique to CK2 and having the hallmark of 
a nuclear localisation signal (NLS) [5], is composed by two 
functionally distinct entities: an N-terminal moiety mostly con- 
cerned with heparin inhibition, as well as with down-regulation 
by fl-subunit (unpublished data), and a carboxyl terminal part 
implicated in the recognition of the crucial specificity determi- 
nant at position +3 [13] but irrelevant to heparin. 
Though the 74 77 quartet appears to be the main site of high 
affinity heparin binding, additional basic residues cooperate 
with it, as indicated by the two orders of magnitude increase 
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Fig. 3. Opposite ffect of holoenzyme r constitution  the susceptibil- 
ity to heparin inhibition of CK2 ~ wild type and its mutant R228A. The 
catalytic activity of CK2 ~ wild type (circles), either alone (o) or com- 
bined with equimolar amounts offl subunit (o) and of CK2 ~ mutant 
R228A (squares), either alone ([]) or combined with equimolar amounts 
offl subunit (m) was assayed with the peptide substrate RRRADDS- 
DDDDD (100 pM) as in Fig.1. 
of ICs0 observed with mutant R 19 l, 195K 198, in which the basic 
stretch 74-77 is preserved. The effect of this mutation isactually 
comparable to that induced by the mutation of just K74 and 
K75 inside the 74-77 stretch [17], although a precise compari- 
son is hampered by the different substrate (casein) used in that 
study. 
In any case our data unambiguously show that the triple 
mutation in the 191-198 loop is much less effective on heparin 
inhibition than the quadruple mutation of the 74-77 cluster, 
which not only abolishes but even subverts the heparin effect 
under comparable conditions (see Fig. 1). Interestingly the op- 
posite is true in the case of CK2 inhibition by poly(Glu,Tyr)4:1 
and by the pseudosubstrate peptide EEEEEYEEEEEEE, the 
efficacy of both being reduced more with mutant 
R191,195K198A than with mutant K74-77A (Table 1). It 
should be noted that inhibition by EEEEEYEEEEEEE is also 
significantly reduced by the triple mutation in the 79 83 se- 
quence (Table 1), which is ineffective on heparin and only 
slightly effective on poly(Glu,Tyr)4:1 inhibition. The somewhat 
different modes of action of the two polyglutamyl inhibitors is 
also outlined by the observation that sensitivity to EEEEEY- 
EEEEEEE is compromised much more severely than that to the 
random co-polymer (compare the alterations in ICs0 values in 
Table 1). In particular the generally modest changes in ICs0 
values of poly(Glu,Tyr)4:l, as compared to EEEEEYEEEE- 
EEE and heparin, may suggest hat additional basic residues 
not mutated in this study are majorly implicated in the mecha- 
nism of poly(Glu,Tyr)4:1 inhibition. In contrast the binding of 
EEEEEYEEEEEEE seems to be almost entirely dependent on 
the basic residues clustered in the 191-198 and 74-83 se- 
quences, whose variable substitutions with alanine causes rises 
of ICs0 value ranging between 10- and 590-fold, suggesting that 
the simultaneous mutation of all these basic residues might fully 
suppress the inhibition by EEEEEYEEEEEEE. This would be 
not unexpected considering that the same basic residues ac- 
count for the recognition of the main substrate specificity deter- 
minants, notably those at positions +3 and +1 [12], which are 
presumably responsible also for the binding of the pseudosub- 
strate. 
The different effects of mutations on heparin and pseudosub- 
strate inhibition may reflect he observation that while the latter 
is a purely competitive inhibitor with respect to the phosphoac- 
ceptor substrate, the actual mode of heparin inhibition remains 
a matter of debate, as discussed in [1], where a number of 
arguments supporting the possibility that heparin might inter- 
act with site(s) partially distinct from the catalytic one are cited. 
Consistent with this interpretation would be also the finding 
that two CK2 mutants partially altered in the 74-77 basic quar- 
tet are not seriously defective in substrate recognition, despite 
their drastically reduced sensitivity to heparin [18,19]. 
An intriguing outcome of this study is the increased sensitiv- 
ity to heparin and to poly(Glu,Tyr)4:l inhibition of mutant 
R228A which does not exhibit any marked alteration in sub- 
strate recognition [12]. How might the suppression of a posi- 
tively charged side chain increase the affinity for polyanionic 
inhibitors i hard to explain, unless assuming an indirect effect. 
It seems conceivable that R228 contributes to attain a molecu- 
lar conformation that makes the binding sites less accessible to 
polyanionic inhibitors. Interestingly the paradoxical effect of 
mutating R228 into alanine is partially dependent on the fl- 
subunit, being less pronounced with the isolated c~-subunit (Fig. 
3). In other words the fl subunit that normally slightly protects 
CK2 ~ against heparin inhibition [7], dramatically increases the 
sensitivity to heparin of this CK2 c~ mutant. This would mean 
that the conformational changes induced by the mutation of 
R228 and leading to an increased sensitivity to heparin inhibi- 
tion, are amplified by the fl subunit. It is conceivable therefore 
Table l 
IC50 values for the inhibition of CK2 wild type and the mutants by heparin, the pseudo-substrate EEEEEYEEEEEEE and poly(Glu,Tyr)4 : 1
ICs0 values 
Heparin (/.tg/ml) EEEEEYEEEEEEE ( t iM)  Poly(GLu,Tyr)4:1 (nM) 
Wild type 0.1040 2.0 3.00 
K74-77A >> 120.0000 600.0 23.00 
K79R80K83A 0.0860 20.0 4.80 
R191,195KI98A 11.4000 1180.0 180.00 
R228A 0.0036 1.0 0.42 
R278K279R280A 0.1300 3.5 3.00 
All the experiments were performed under comparable condition, with the same concentration fthe peptide substrate RRRADDSDDDDD (100 
~M) and of the enzymes (3.3 pg/ml). The values hown are the mean of at least 3 experiments with a standard error never exceeding 15%. 
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that R228 is implicated in some kind of functional interaction 
with the fl subunit. 
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